The binding of these six components to inflammatory mediators (IL-6, TNF-α, IL-1β) and Alzheimer’s disease-related protein targets was studied by molecular docking technology, and it was found that these six components all have low binding energy and good binding fraction. The gene discussed is IL6; the disease is Alzheimer disease.